GLP-1RAs may effectively alleviate clinical symptoms in COPD patients, improve airflow limitation, mitigate airway damage, fibrosis, and remodeling, shorten hospital stays, reduce the economic burden, and lower the risk of COPD-related complications
Ethical Approval This study was assessed using the decision tool on the HRA website [ Ethics committee approval was not required, as the analysis was conducted as part of a service-based evaluation project to examine the effects of semaglutide therapy, which is routine in our local practice
Handling dose escalation side effects The transition periods, especially from 2mg to 4mg and from 4mg to 8mg, are where most side effects occur
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinsons disease
OA synovitis directly contributes to several clinical signs and symptoms, including joint swelling and effusion, and reflects the structural progression of the disease 8,9
Why are researchers interested in GIP and GLP-1